Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cellvation Tackling Traumatic Brain Injuries With Stem Cell Therapy

Executive Summary

Emerging Company Profile: With mononuclear stem cell therapy from University of Texas research, new company hopes to address traumatic brain injury by reducing the pro-inflammatory cytokine cascade, which exacerbates the initial injuries in severe TBI.

Advertisement

Related Content

Fortress Adds New Rare Disease-Focused Subsidiary
Tech Transfer Roundup: Entrepreneurial Culture Matters
Fujifilm Promises A Shake-Up Of Regenerative Medicines Market
CicloMulsion Trial Failure Leaves NeuroVive Dependent On NeuroSTAT
How Are Japan’s New Regenerative Medicine Regulations Playing Out?
Tech Transfer Deals, April 2015
Japan Regenerative Medicine Laws Take Effect, Encourage Industry

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097624

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel